There are a wide variety of surgical therapeutic options for GERD—ranging from laparoscopic fundoplication, magnetic sphincter augmentation, to advanced endoscopic interventions (eg, transoral incisionless fundoplication, TIF). TIF has emerged as the predominant endoscopic approach for GERD, supported by several randomized trials highlighting the efficacy of this procedure. Its safety profile has similarly been well established. The key to properly utilizing this procedure is patient selection. We here in describe the efficacy, highlight key decision making and technical aspects of performing a TIF, to discuss post-operative care and complications.
YadlapatiRPandolfinoJE.Personalized approach in the work-up and management of gastroesophageal reflux disease. Gastrointest Endosc Clin N Am. 2020;30(2):227-238. doi:10.1016/j.giec.2019.12.002
KatzPODunbarKBSchnoll-SussmanFHGreerKBYadlapatiRSpechlerSJ.ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022;117(1):27-56. doi:10.14309/ajg.0000000000001538
4.
RinsmaNFSmeetsFGBrulsDW, et al. Effect of transoral incisionless fundoplication on reflux mechanisms. Surg Endosc. 2014;28(3):941-949. doi:10.1007/s00464-013-3250-7
5.
IhdeGMDillLAListerDG, et al. A comparison of the endoscopic and laparoscopic view of the gastroesophageal junction in the use of transoral fundoplication. Am J Surg. 2015;210(6):1018-1022; discussion 1022-3. doi:10.1016/j.amjsurg.2015.06.028
6.
NguyenNTThosaniNCCantoMI, et al. The American Foregut Society white paper on the endoscopic classification of esophagogastric junction integrity. Foregut. 2022;2(4):339-348. doi:10.1177/26345161221126961
JobeBAO’RourkeRWMcMahonBP, et al. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg. 2008;248(1):69-76. doi:10.1097/SLA.0b013e31817c9630
9.
TradKSBarnesWESimoniG, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial. Surg Innov. 2015;22(1):26-40. doi:10.1177/1553350614526788
10.
TradKSBarnesWEPrevouER, et al. The TEMPO trial at 5 years: transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective. Surg Innov. 2018;25(2):149-157. doi:10.1177/1553350618755214
11.
HuangXChenSZhaoH, et al. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis. Surg Endosc. 2017;31(3):1032-1044. doi:10.1007/s00464-016-5111-7
12.
JainDSinghalS. Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand?Clin Endosc. 2016 Mar; 49(2):147-56. doi: 10.5946/ce.2015.044. Epub 2016 Feb 15.
13.
TestoniPATestoniSMazzoleniGVailatiCPassarettiS.Long-term efficacy of transoral incisionless fundoplication with esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc. 2015;29:2770-2780. doi:10.1007/s00464-014-4008-6
14.
ChoiAYRoccatoMKSamarasenaJB, et al. Novel interdisciplinary approach to GERD: concomitant laparoscopic hiatal hernia repair with transoral incisionless fundoplication. J Am Coll Surg. 2021;232(3):309-318. doi:10.1016/j.jamcollsurg.2020.11.021
15.
HoganWJ.Clinical trials evaluating endoscopic GERD treatments: is it time for a moratorium on the clinical use of these procedures?Am J Gastroenterol. 2006;101(3):437-439. doi:10.1111/j.1572-0241.2006.00523.x
16.
EvansRJMooreR.Hiatal width: a novel measure of hiatal hernia: 480. Am J Gastroenterol. 2018;113:S276-S277.
